Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activity by Li, Juying et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: ARTICLE
© The Rockefeller University Press    $30.00
The Journal of Cell Biology, Vol. 181, No. 2, April 21, 2008 321–333
http://www.jcb.org/cgi/doi/
JCB 321
10.1083/jcb.200711082
  Correspondence to J. Yuan: jyuan@hms.harvard.edu 
  Abbreviations used in this paper: Aip1, actin-interacting protein 1; CARD, 
caspase recruitment domain; CrmA, cytokine response modiﬁ  er A; GLD, gelsolin-
like domain; HSS, high-speed supernatant; IL-1    , interleukine-1    ; LPS, lipopoly-
saccharide; LRR, leucine-rich repeat; LRRFIP2, LRR in Flightless-I  –  interacting protein 2; 
LSP, low-speed pellet; shRNA, short hairpin RNA; TLR, toll-like receptor; wt, 
wild type. 
    The online version of this paper contains supplemental material.   
        Introduction 
  Caspases are a family of cysteine proteases regulating both 
apoptosis and infl  ammation (  Cryns and Yuan, 1998  ). Caspases 
are divided into two subfamilies based on their major functions 
in vivo, proapoptotic subfamily, or proinfl  ammatory subfamily 
(  Martinon and Tschopp, 2004  ). The proapoptotic subfamily 
of caspases (caspase-3, -6, -7, -8, -9, and -10) mediates a cas-
cade of proteolytic cleavage events that culminate in apoptotic 
cell death. However, human caspase-1, -4, and -5 and mouse 
caspase-11 and -12 constitute another group referred to as the 
  caspase-1 subfamily of proinfl  ammatory caspases. Importantly, 
the activation of caspase-1 results in the cleavage and activation 
of the proinfl  ammatory cytokines interleukine-1     (IL-1  )  and 
IL-18 (  Thornberry et al., 1992  ;   Ghayur et al., 1997  ;   Gu et al., 
1997  ). Although caspase-11 does not process pro-IL-1     di-
rectly, coexpression of caspase-11 with caspase-1 promotes the 
activity of caspase-1 in processing pro-IL-1     (  Wang et al., 1996  ). 
Both caspase-1 – defi  cient mice ( Kuida et al., 1995 ;  Li et al., 1995 ) 
and caspase-11  –  defi  cient mice (  Wang et al., 1998  ) develop 
normally but have a defect in the maturation of IL-1     and are 
resistant to the lethal effect of endotoxins, which indicates the 
importance of the proper regulation of proinfl  ammatory caspases 
in host defense. Several viral proteins, e.g., cytokine response 
modifi  er A (CrmA) and p35, acting as pseudosubstrates, are potent 
caspase-1 inhibitors produced by the viruses to dampen IL-1    
secretion and apoptosis during host defense response (  Clem 
et al., 1991  ;   Ray et al., 1992  ). In addition, the serpin PI9 has 
been identifi  ed as a human homologue of CrmA (  Sprecher 
et al., 1995  ). The reactive center of PI9 shows 54% identity with 
CrmA and contains a Glu residue at the P1 position rather than 
the Asp found in CrmA (  Annand et al., 1999  ). It has been shown 
that PI9 inhibits active caspase-1 in vitro (  Annand et al., 1999  ) 
and in human vascular smooth muscle cells ( Young et al., 2000 ). 
PI9 also inhibits apical proapoptotic caspases and death receptor  –
  mediated apoptosis (  Kummer et al., 2007  ). However, the ex-
pression of PI9 in monocytes/macrophages is relatively low and 
is further diminished after lipopolysaccharide (LPS) stimula-
tion or differentiation (  Young et al., 2000  ). 
  Flightless-I protein, originally identifi  ed from a   Drosophila 
melanogaster   mutant unable to fl  y (  Campbell et al., 1993  ), contains 
a C-terminal gelsolin-like domain (GLD) and belongs to the gelsolin 
superfamily of actin-remodeling proteins (  Silacci et al., 2004 ). 
C
aspase-1 and caspase-11 are proinﬂ  ammatory 
caspases that regulate cytokine production and 
leukocyte migration during pathogen infection. 
In an attempt to identify new intracellular regulators of cas-
pase-11, we found that Flightless-I, a member of the gelso-
lin superfamily of actin-remodeling proteins, interacts and 
regulates both caspase-11 and caspase-1. Flightless-I tar-
gets caspase-11 to the Triton X-100  –  insoluble cytoskeleton 
fraction and the cell leading edge. In addition, Flightless-I 
inhibits caspase-1 activation and caspase-1  –  mediated 
interleukine-1     (IL-1    ) maturation. The physiological 
relevance of these ﬁ  ndings is supported by the opposing 
effects of Flightless-I overexpression and knockdown on 
caspase-1 activity and IL-1     maturation. Our results sug-
gest that Flightless-I may be a bona ﬁ  de caspase-1 inhibi-
tor that acts through a mechanism similar to that of cytokine 
response modiﬁ   er A, a potent caspase-1 inhibitor from 
the cowpox virus. Our study provides a new mechanism 
controlling the localization and activation of proinﬂ  amma-
tory caspases.
  Flightless-I regulates proinﬂ  ammatory caspases 
by selectively modulating intracellular localization 
and caspase activity 
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Western blotting using anti-HA and anti – Flightless-I antibodies. 
Interestingly, Flightless-I interacted with caspase-11 regardless 
of LRRFIP2 coexpression (  Fig. 1 B  ) and LRRFIP2 coimmuno-
precipitated with caspase-11 only when Flightless-I was co-
expressed. This result suggests that the interaction between 
caspase-11 and LRRFIP2 might be mediated through Flight-
less-I. We probed a Western blot of the protein elute from the 
original affi  nity purifi  cation experiment with anti  –  Flightless-I 
antibody and confi  rmed the presence of signifi  cantly higher 
amount of Flightless-I in the J774-C11-C254G immunocomplex 
than in the control (  Fig. 1 A  , right). 
  Flightless-I (144 kD) contains an N-terminal LRR domain 
and a C-terminal GLD (  Fig. 1 C  ); the latter is responsible for 
actin binding (  Liu and Yin, 1998  ). Caspase-11 contains an 
N-terminal CARD (caspase recruitment domain), which is fol-
lowed by the cysteine protease catalytic domain (the p30 domain; 
  Fig. 1 C  ). To determine the binding domains between Flight-
less-I and caspase-11, we generated a series of expression con-
structs for the full-length and truncated mutants of Flightless-I 
and caspase-11. Caspase-11 coimmunoprecipitated with the 
full-length Flightless-I as well as with the LRR or GLD of 
Flightless-I (  Fig. 1 D  ). Flightless-I interacted with the full-
length and p30 domain of caspase-11 much more strongly than 
with the CARD domain of caspase-11 (  Fig. 1 E  ). This mode of 
interaction between Flightless-I and caspase-11 is different 
from the interaction between Aip1 and caspase-11, which is 
mediated through the CARD domain but not the p30 domain of 
caspase-11 (  Li et al., 2007  ). 
  Overexpression of Flightless-I changes the 
subcellular distribution of caspase-11 
  Because Flightless-I is an actin-binding protein, we fractionated 
Triton X-100 cell extracts into different pools by differential 
centrifugation (  Fig. 2 A  ;   Yamamoto et al., 2001  ). Low-speed 
centrifugation sediments highly cross-linked actin fi  laments 
(low-speed pellet [LSP]). Actin fi  laments that are not cross-linked 
into thick bundles can be sedimented into a high-speed pellet by 
centrifugation at a higher speed. Actin monomers and short olig-
omers remain in the high-speed supernatant (HSS). Flightless-I 
was preferentially present in the Triton X-100  –  insoluble fraction, 
mostly in the LSP when it was expressed in 293T cells, which 
suggests that Flightless-I might prefer to bind cross-linked actin 
fi  laments. The preference of Flightless-I for the LSP was not af-
fected by coexpression of the full-length or the truncated forms 
of caspase-11 (  Fig. 2 B  ). Unlike Flightless-I, Aip1, also an actin-
binding protein, was preferentially present in the Triton X-100  –
  soluble HSS fraction (  Fig. 2 C  ). This is consistent with the 
relatively low affi  nity of Aip1 for F-actin (  Ono, 2003  ). 
  Caspase-11 was predominantly associated with the Triton 
X-100  –  soluble HSS fraction. However, a small fraction of both 
the full-length and the p30 domain but not the CARD domain of 
caspase-11 could be detected in the Triton X-100  –  insoluble frac-
tion ( Fig. 2 D ). Coexpression of Flightless-I increased the amount 
of the full-length and p30 domain of caspase-11 in the Triton 
X-100  –  insoluble LSP fraction, which is consistent with their 
ability to bind to Flightless-I. In contrast, the CARD domain, 
which is much weaker in its ability to interact with Flightless-I 
Although there is evidence that Flightless-I regulates the actin 
cytoskeleton, its GLD is far more divergent from that in many 
other gelsolin family members, which suggests that the GLD of 
Flightless-I may have other unique regulatory functions. In addi-
tion, Flightless-I has an N-terminal leucine-rich repeat (LRR) 
protein  –  protein interaction domain that has many identifi  ed 
binding partners, including FLAP1 and LRR in Flightless-I  –
  interacting proteins (LRRFIPs;   Liu and Yin, 1998  ;   Fong and 
de Couet, 1999  ). The unique important role of Flightless-I is 
supported by the fi  nding that Flightless-I  –  defi  cient mice are 
embryonic lethal (  Campbell et al., 2002  ), whereas mice defi  cient 
in several other gelsolin family proteins (e.g., gelsolin, villin, 
and capG) are not (  Witke et al., 1995, 2001  ;   Pinson et al., 1998  ). 
The human Flightless-I gene maps within the microdeletion 
critical region of Smith-Magenis Syndrome, which is associ-
ated with a spectrum of developmental and behavioral abnor-
malities (  Chen et al., 1995  ). 
  Through a Flag tag  –  based affi  nity purifi  cation approach, 
we identifi  ed Flightless-I as a new caspase-11  –  binding protein. 
Here, we show that Flightless-I regulates two major proinfl  am-
matory caspases, caspase-11 and caspase-1, in multiple ways. 
Flightless-I regulates the subcellular distribution of caspase-11 
by promoting its localization at the cell leading edge. Further-
more, Flightless-I inhibits caspase-1 activation in a manner 
similar to CrmA. 
  Results 
  Identiﬁ  cation of Flightless-I as a 
caspase-11  –  binding protein 
  We have previously found that caspase-11 promotes actin de-
polymerization and leukocyte migration through interaction 
with Aip1 (actin-interacting protein 1;   Li et al., 2007  ). In the 
previous study (  Li et al., 2007)  , we established two stable 
cell lines of mouse macrophage-like J774 cells expressing an 
N-terminal Flag-tagged enzymatic activity site C254G mutant 
form of caspase-11 (J774-C11-C254G) or a control vector 
(J774-pBabe). Total lysates of LPS-treated J774-C11-C254G 
and J774-pBabe cells were affi  nity purifi  ed using an anti-Flag 
(M2) agarose column, and the proteins eluted by the Flag pep-
tide were analyzed by SDS-PAGE. In addition to Aip1 (66 kD), 
we recovered a second protein in the affi  nity-purifi  ed proteins 
from J774-C11-C254G cells with molecular mass of    50  kD 
(  Fig. 1 A  , left). Mass spectrometry analysis revealed that it is 
mouse LRRFIP2. 
 We  fi  rst attempted to reproduce the interaction of cas-
pase-11 and LRRFIP2 using coimmunoprecipitation after cotrans-
fection of expression vectors encoding caspase-11 and LRRFIP2 
but failed to detect any interaction (  Fig. 1 B  ). LRRFIP2 was 
originally identifi  ed from a yeast two-hybrid screen using the 
LRR region of Flightless-I as the bait (  Fong and de Couet, 1999  ). 
We examined the possibility that Flightless-I might be required 
for LRRFIP2 to interact with caspase-11. We cotransfected 
Flag-tagged caspase-11, HA-tagged LRRFIP2, and nontagged 
Flightless-I expression constructs into 293T cells. The cell ly-
sates were immunoprecipitated with anti-Flag agarose beads 
and the immunity-purifi  ed protein complexes were analyzed by 323 FLIGHTLESS-1 REGULATES CASPASES   •   LI ET AL.
  To further characterize the subcellular localization of cas-
pase-11 and Flightless-I by immunofl  uorescence, we expressed 
EGFP-tagged caspase-11 (caspase-11  –  EGFP) in HeLa and 
COS cells. Caspase-11 was predominantly localized in the cy-
tosol (  Fig. 2 E  ). Flightless-I has been shown to colocalize with 
actin arcs, membrane ruffl  es, and the leading edge of migrating 
fi  broblasts after serum stimulation (  Davy et al., 2001  ). When 
we expressed an HA-tagged Flightless-I expression vector in 
as compared with that of the full-length or p30 domain of 
  caspase-11 (  Fig. 1 E  ), remained in the HSS fraction regardless 
of Flightless-I expression (  Fig. 2 D  ). Finally, the distribution 
of caspase-11 did not change signifi  cantly when Aip1 was co-
expressed (  Fig. 2 D  ). Collectively, these results suggest that the 
increased partition of the full-length or p30 domain of cas-
pase-11 into the Triton X-100  –  insoluble LSP fraction is dependent 
on Flightless-I binding. 
  Figure 1.       Identiﬁ  cation of Flightless-I as a caspase-11  –  binding protein.   (A) Afﬁ  nity puriﬁ  cation of caspase-11  –  interacting proteins. The cell lysates of J774 
cells stably expressing an N-terminal Flag-tagged caspase-11 active site mutant (C11-C254G) or vector alone (pBabe) were afﬁ  nity puriﬁ  ed through an 
anti-Flag M2 agarose column and the proteins bound to the column were separated by 12% SDS-PAGE and stained by Gelcode blue dye. A 50-kD protein 
speciﬁ  c for J774 C11-C254G cells (arrow) was identiﬁ  ed by mass spectrometry to be LRRFIP2 (left). A Western blot analysis of afﬁ  nity-puriﬁ  ed proteins using 
an anti  –  Flightless-I antibody conﬁ  rmed the presence of Flightless-I in the immunopuriﬁ  ed protein complex from J774 C11-C254G cells (right). FliI, Flightless-I. 
(B) LRRFIP2 interacts with caspase-11 through Flightless-I. The cell lysate of 293T cells expressing Flag-tagged caspase-11, HA-tagged LRRFIP2, and nontagged 
Flightless-I was immunoprecipitated with anti-FLAG M2 beads. Western blots of the immunocomplexes were probed with anti-HA, anti-Flightless-I, or anti-
  caspase-11 antibodies. (C) A diagram of Flightless-I and caspase-11. (D) Both the LRR domain and the GLD domain of Flightless-I interact with caspase-11. 
The cell lysate of 293T cells expressing Flag-tagged caspase-11 and HA-tagged full-length or truncated mutants of Flightless-I was immunoprecipitated with anti-
Flag M2 beads. Western blots of the immunocomplexes and the lysate input were probed with anti-HA or anti  –  caspase-11 antibodies. (E) The p30 domain of cas-
pase-11 interacts with Flightless-I. The lysate of 293T cells expressing Flag-tagged full-length or truncated mutants of caspase-11 and HA-tagged Flightless-I was 
immunoprecipitated with anti-Flag M2 beads. Western blots of the immunocomplexes and the lysate input were probed with anti-HA or anti-Flag antibodies.     JCB • VOLUME 181 • NUMBER 2 • 2008  324 
  Figure 2.       Overexpression of Flightless-I changes the subcellular distribution of caspase-11.   (A) Fractionation of Triton X-100 cell extract by differential 
centrifugation. HSP, high-speed pellet; Ppt, pellet; Sup, supernatant. (B and C) Distribution of Flightless-I and Aip1 among Triton X-100  –  soluble (TS) and 
insoluble (TI) fractions. The cell lysates of 293T cells expressing HA-tagged Flightless-I (B) or Aip1 (C) and Flag-tagged caspase-11 were fractionated 
as in A. Equal fractions of each pool were electrophoresed on SDS-PAGE and subjected to Western blotting with anti-HA or anti-actin antibodies. FliI, 
Flightless-I. Arrowhead indicates the cleavage product of Flightless-I. (D) Overexpression of Flightless-I but not Aip1 increased the distribution of 
caspase-11 in the Triton X-100  –  insoluble LSP fraction. The cell lysate of 293T cells expressing indicated proteins was fractionated as in A. Western 
blots of the proteins in each pool were probed with anti-Flag or anti-actin antibodies. (E) Subcellular localization of caspase-11 in HeLa and COS cells. 
C-terminal EGFP-tagged caspase-11 was overexpressed in HeLa and COS cells (green). F-actin was stained with rhodamine-conjugated phalloidin 
(red). (F) Subcellular localization of Flightless-I in HeLa and COS cells. HA-tagged Flightless-I was overexpressed in HeLa and COS cells and stained 
with a rat anti-HA primary antibody and an anti  –  rat-IgG  –  Alexa 488 secondary antibody (green). F-actin (red) was stained as in E. (G) Colocalization 
of Flightless-I and caspase-11 at the cell leading edge. EGFP-tagged caspase-11 (a, e, and i) and HA-tagged Flightless-I (b, f, and j) were coexpressed 
in HeLa and COS cells. Flightless-I was stained with mouse anti-HA primary antibody and anti  –  mouse-IgG  –  Alexa 594 (b, red) or Alexa 647 (f and j, 
blue) secondary antibody. F-actin was stained with rhodamine-conjugated phalloidin (d and h, red). Arrows indicate the leading edge. Bars: (E and F) 
30   μ  m; (G) 15   μ  m.     325 FLIGHTLESS-1 REGULATES CASPASES   •   LI ET AL.
duction, and caspase-11 itself was cleaved into p30 (  Fig. 3 D  , 
lane 3). Coexpression of Flightless-I signifi  cantly inhibited 
caspase-1 activation and reduced IL-1     production 84% (  Fig. 3 D  , 
lane 4). The addition of pan-caspase inhibitor zVAD-fmk to-
gether with Flightless-I coexpression further inhibited cas-
pase-1 activation and IL-1     production (  Fig. 3 D  , lane 6). 
These results suggest that Flightless-I might function as a cas-
pase-1 inhibitor. 
  To determine whether Flightless-I could inhibit caspase-1  –
  induced apoptosis, we transfected HeLa cells with either a 
Flag-tagged caspase-1 expression vector alone or caspase-1 
together with HA-tagged Flightless-I constructs and immuno-
stained transfected cells with anti-Flag and anti-HA anti-
bodies. As shown in  Fig. 3 E , 24 h after transfection, expression 
of caspase-1 induced apoptosis with typical blebbing mor-
phology in 6.2   ±   3.4% of transfected cells that were still at-
tached to the coverslips ( Fig. 3 E , a, arrows). When Flightless-I 
and caspase-1 expression constructs were cotransfected, apop-
totic cells were found to express only caspase-1 (  Fig. 3 E  , b, 
arrow). None of the cells that expressed both caspase-1 and 
Flightless-I were apoptotic in all the fi  elds examined (  Fig. 3 E  , 
b and c). These results indicate that Flightless-I could inhibit 
caspase-1 – induced  apoptosis. 
  To determine whether Flightless-I could directly in-
hibit caspase-1 activity in vitro, we preincubated recombinant 
  caspase-1 with either GST or GST-tagged Flightless-I and ex-
amined the caspase-1 activity in cleaving in vitro translated 
[ 
35  S]Met-labeled substrate pro-IL-1     (  Fig. 4 A  ). GST and GST-
tagged Flightless-I had no effect on pro-IL-1     processing at 
0.014   μ  M. At a concentration above 1.4   μ  M, compared with 
GST, GST-tagged Flightless-I showed an inhibitory effect on 
caspase-1 – mediated  mature  IL-1    production. To confi  rm this 
result, we also tested the activity of caspase-1 in cleaving col-
orimetric peptide substrate Ac-YVAD-pNA (  Fig. 4 B  ). In this 
assay, GST-tagged Flightless-I showed a signifi  cant inhibitory 
effect on caspase-1 activity at 0.3   μ  M, whereas GST had no 
effect at this concentration. CrmA is a more potent inhibitor of 
caspase-1 than Flightless-I (Fig. S2 B;   Komiyama et al., 1994  ). 
In contrast, GST-tagged Flightless-I did not signifi  cantly inhibit 
caspase-11 activity compared with GST alone at the similar 
concentrations at which Flightless-I could inhibit caspase-1 ac-
tivity (  Fig. 4 C  ). Flightless-I did not inhibit caspace-11  –  induced 
cell death in HeLa cells (Table S1, available at http://www.jcb
.org/cgi/content/full/jcb.200711082/DC1). 
  Knockdown of endogenous Flightless-I 
enhances caspase-1 activity 
  To examine whether endogenous Flightless-I functions as a 
caspase-1 inhibitor, we transiently knocked down endogenous 
Flightless-I in J774 cells using synthetic siRNA oligos. Three 
independent siRNA oligos targeting different coding regions of 
Flightless-I signifi  cantly reduced the endogenous protein levels 
of Flightless-I (  Fig. 5 A  ). The levels of caspase-1 were not 
affected in these three Flightless-I transient knockdown cells 
(  Figs. 5 B   and S3 A, available at http://www.jcb.org/cgi/
content/full/jcb.200711082/DC1). In response to LPS plus ATP 
stimulation, mature IL-1     secretion was signifi  cantly increased 
HeLa and COS cells, we could detect Flightless-I in the cytosol 
as well as at the cell leading edge by immunofl  uorescence using 
an anti-HA antibody (  Fig. 2 F  ). In cells coexpressing caspase-11  –
 EGFP and HA-tagged Flightless-I, there was an increased local-
ization of caspase-11 at the cell leading edge, where caspase-11 
colocalized with Flightless-I (  Fig. 2 G  , a  –  c, arrow) as well as 
the F-actin  –  rich region (  Fig. 2 G  , d  –  k, arrows). These results 
suggest that by interacting with caspase-11, Flightless-I might 
be able to bring caspase-11 to the F-actin  –  rich region at the cell 
leading edge. 
  Flightless-I inhibits caspase-1 activation 
in vivo and in vitro 
  Caspase-11 belongs to the caspase-1 subfamily of proinfl  am-
matory caspases. The amino acid sequences of caspase-11 and 
caspase-1 at the catalytic domain (p30 domain) are 50% iden-
tical, whereas the sequences in the CARDs are more diver-
gent (21% identical;   Wang et al., 1996  ). Because Flightless-I 
interacts with caspase-11 through the highly conserved p30 
domain, we went on to examine whether Flightless-I could 
interact with caspase-1 as well. As shown in   Fig. 3 A  , Flight-
less-I but not LRRFIP2 coimmunoprecipitated with Flag-
tagged caspase-1 in 293T cells. Similar to that of caspase-11 
(  Fig. 1 D  ), caspase-1 could interact with both the LRR do-
main and the GLD domain of Flightless-I (  Fig. 3 A  ). Endog-
enous caspase-1 and Flightless-I also interact in J774 cells 
(Fig. S1 A, available at http://www.jcb.org/cgi/content/full/
jcb.200711082/DC1). The interaction of Flightless-I with pro-
infl  ammatory caspases is specifi  c because Flightless-I did not 
bind to caspase-9 (Fig. S1 B). Expression of caspase-11 did not 
interfere with the binding between Flightless-I and caspase-1 
(Fig. S1 C). 
  To examine whether the expression of Flightless-I could 
affect caspase-1 activation, we coexpressed caspase-1 and 
Flightless-I in 293T cells. Overexpression of caspase-1 in-
duced autocleavage, as evidenced by the appearance of p20 
(  Fig. 3 B  , arrowheads). Interestingly, coexpression of Flight-
less-I signifi  cantly inhibited caspase-1 self-cleavage in a dose-
dependent manner (  Fig. 3, B and C  ; and Fig. S2 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200711082/DC1). 
The expression of the LRR and GLD domains of Flightless-I 
also had an inhibitory effect, though to a less extent compared 
with full-length Flightless-I (  Fig. 3, B and C  ). In contrast, 
the expression of X-linked inhibitor of apoptosis protein or 
cellular inhibitor of apoptosis 1, inhibitors of caspase-3 and 
caspase-9 (  Deveraux and Reed, 1999  ), did not inhibit caspase-1 
activation (  Fig. 3 B  ). 
  Caspase-1 cleaves pro-IL-1     to generate mature IL-1    
(  Thornberry et al. 1992  ). To examine whether Flightless-I 
could inhibit IL-1     maturation mediated by caspase-1, we co-
expressed pro-IL-1  , caspase-1, and Flightless-I in 293T cells. 
Mature IL-1     secreted into the culture media was detected by 
ELISA (  Fig. 3 D  , right). Overexpression of caspase-1 induced 
self-activation as well as mature IL-1     production (  Fig. 3 D  , 
lane 2), as has been reported (  Wang et al., 1996  ). Caspase-11 
is an activator of caspase-1 (  Wang et al., 1996  ). Coexpression 
of caspase-11 enhanced caspase-1 activation and IL-1     pro-JCB • VOLUME 181 • NUMBER 2 • 2008  326 
  Figure 3.       Flightless-I inhibits caspase-1 activation in vivo.   (A) Caspase-1 interacts with Flightless-I. The cell lysates of 293T cells expressing indicated 
proteins were immunoprecipitated with anti-Flag M2 beads. Western blots of the immunocomplexes and the lysate input were probed with anti  –  caspase-1 
or anti-HA antibodies. FliI, Flightless-I. (B) Overexpression of Flightless-I but not cellular inhibitor of apoptosis 1 or X-linked inhibitor of apoptosis protein 
inhibit the self-cleavage of caspase-1. Expression plasmids encoding caspase-1 (0.2   μ  g) and other indicated proteins (1   μ  g) were cotransfected into 293T 
cells. The Western blot of cell lysates was probed using an anti  –  caspase-1 antibody. Arrowheads indicate the cleavage products of caspase-1. (C) Flight-
less-I inhibits the self-cleavage of caspase-1 in a dose-dependent manner. Expression constructs of full-length or truncated mutants of Flightless-I at indicated 
amounts were cotransfected with the expression vector of caspase-1 (0.2   μ  g) into 293T cells. The Western blot of cell lysates was probed against an 
anti  –  caspase-1 antibody. (D) Flightless-I inhibits caspase-1  –  dependent IL-1     maturation in vivo. Expression vectors encoding caspase-1 (0.2   μ  g) and other 
indicated proteins (1   μ  g) were cotransfected into 293T cells. The Western blots of cell lysates were probed against anti  –  pro-IL-1    , anti  –  caspase-1, anti  –
  caspase-11, or anti-tubulin antibodies. The amount of mature IL-1     secreted into the culture supernatants was measured using ELISA. Arrowheads indicate 
the cleavage products of caspase-1. Error bars represent SD of triplicates. (E) Flightless-I inhibits caspase-1  –  induced apoptosis. An expression vector en-
coding Flag-tagged caspase-1 was transfected into HeLa cells with or without the expression construct of HA-tagged Flightless-I. 24 h after transfections, 
cells were ﬁ  xed. The distribution of caspase-1 was determined by immunostaining with mouse anti-Flag primary antibody and anti  –  mouse-IgG  –  Alexa 594 
secondary antibody (red). The distribution of Flightless-I was determined by immunostaining with rat anti-HA primary antibody and anti  –  rat-IgG  –  Alexa 488 
secondary antibody (green). Bar, 30     m.     327 FLIGHTLESS-1 REGULATES CASPASES   •   LI ET AL.
Flightless-I on caspase-1 when the endogenous Flightless-I 
level was reduced. Therefore, we further examined the protein 
levels of pro-IL-1     and caspase-11 in Flightless-I transient knock-
down cells. Consistent with the study of Wang et al. (  2006  ), the 
protein level of pro-IL-1   was higher in Flightless-I knockdown 
cells than in control cells after LPS stimulation (  Figs. 5 D   and 
S3 B). However, the caspase-11 protein level did not change 
signifi  cantly in Flightless-I knockdown cells compared with 
control cells (  Fig. 5 D  ). 
  To directly address the issue of whether caspase-1 activity 
was affected when the endogenous Flightless-I level was re-
duced, we further characterized the Flightless-I knockdown 
cells. We generated short hairpin RNA (shRNA) of Flightless-I 
in a pSRP retroviral vector using the same targeting sequence as 
siRNA No. 1 and stably knocked down endogenous Flightless-I 
in J774 cells (  Fig. 5 E  ). Similar to transient knockdown cells 
in Flightless-I knockdown cells compared with control cells 
(  Fig. 5 C  ). This result suggests that the LPS-induced endog-
enous caspase-1 activation that is required for cleaving pro-IL-1     
into mature IL-1     may be enhanced when the endogenous level 
of Flightless-I is reduced. 
  Flightless-I has been reported to negatively modulate the 
LPS-induced toll-like receptor (TLR) pathway by interfering with 
the TLR4 and MyD88 interaction to reduce nuclear factor-   B 
(NF-    B) activation (  Wang et al., 2006  ). Because both pro-
IL-1     and caspase-11 are transcriptional targets of NF-   B  in 
response to LPS stimulation (  Cogswell et al., 1994  ;   Schauvliege 
et al., 2002  ), we considered the possibility that increased IL-1    
production in the Flightless-I knockdown cells might result 
from the increased pro-IL-1     synthesis or increased caspase-1 
activity caused by the higher level of upstream activator cas-
pase-11 rather than directly relieving the inhibitory effect of 
  Figure 4.       Flightless-I inhibits caspase-1 activation in vitro.   (A) Flightless-I inhibits caspase-1  –  dependent pro  –  IL-1     processing in vitro. Recombinant 
caspases-1 (0.2 U) was preincubated with GST or GST-tagged Flightless-I (GST-FliI) at 30  °  C for 1 h and then reacted with [ 
35  S]Met-labeled in vitro translated 
pro  –  IL-1     for another 1.5 h at 30  °  C in 20-  μ  l volume. The cleavage of pro-IL-1     into IL-1     was visualized by autoradiography. (B) Flightless-I inhibits caspase-1 
activity in vitro. Recombinant caspase-1 (1 U) was preincubated with GST or GST-tagged Flightless-I (GST-FliI) at 37  °  C for 30 min and caspase-1 activity 
was measured using the colorimetric substrate Ac-YVAD-pNA at OD 405 nm in 100-  μ  l volume. Error bars represent SD of duplicates. Abs, absorbance 
at OD 405 nm; K (Abs/min), the rate of hydrolysis. (C) Flightless-I does not inhibit caspase-11 activity in vitro. The recombinant p30 domain of 10   μ  g 
caspase-11 was preincubated with GST or GST-tagged Flightless-I (GST-FliI) at 37  °  C for 30 min and caspase-11 activity was measured using colorimetric 
substrate, Ac-LEHD-pNA at OD 405 nm in 100-  μ  l volume.     JCB • VOLUME 181 • NUMBER 2 • 2008  328 
Mature IL-1     production in Flightless-I stable knockdown cells 
(FliIshR1) was increased to a similar extent as in the transient 
knockdown cells (FliIsiR1;   Fig. 5, G and C  ). We measured the 
(  Fig. 5 D  ), Flightless-I stable knockdown cells (FliIshR1) 
showed enhanced protein levels of pro-IL-1     but not caspase-11 
compared with control cells (pSRP) after LPS stimulation ( Fig. 5 F ). 
  Figure 5.       Knockdown of endogenous Flightless-I enhances caspase-1 activity.   (A) Transient knockdown of endogenous Flightless-I in J774 cells using Thermo 
Fisher Scientiﬁ  c synthetic siRNA oligos. Nos. 1, 3, and 4 are three different siRNA oligos targeting Flightless-I. ctl, nontargeting control siRNA oligo. (B) The 
expression levels of caspase-1 in Flightless-I transient knockdown cells with or without 12 h of LPS (1   μ  g/ml) treatment. n.s., a nonspeciﬁ  c band recognizable 
by an anti  –  caspase-1 antibody. (C) IL-1     secretion was increased in Flightless-I transient knockdown cells in response to LPS plus ATP stimulation. 6   ×   10 
4   
control and Flightless-I transient knockdown cells were incubated with 1   μ  g/ml LPS for 12 h then stimulated with 5   μ  M ATP for 30 min. The amount of secreted 
IL-1     in the culture supernatant was measured by ELISA. (D) The expression levels of pro-IL-1     and caspase-11 in Flightless-I transient knockdown cells with 
or without 12 h of LPS (1   μ  g/ml) treatment. (E) Stable knockdown of endogenous Flightless-I in J774 cells by shRNA1 in a retroviral pSRP vector. shRNA1 
targets the same sequence on Flightless-I as siRNA1 in A. (F) The expression levels of caspase-1, pro-IL-1    , and caspase-11 in Flightless-I stable knockdown 
cells (FliIshR1) and control cells (pSRP) with or without 1   μ  g/ml LPS treatment for 6 or 12 h. F, FliIshR1; P, pSRP. (G) IL-1     secretion was increased in Flight-
less-I stable knockdown cells in response to LPS plus ATP stimulation. The experimental procedures were the same as in C. (H) Active caspase-1 and active 
caspase-11 levels in Flightless-I stable knockdown cells (FliIshR1) and control cells (pSRP). Cell lysates from untreated or 12-h LPS (1   μ  g/ml) treated cells were 
incubated with biotinylated YVAD-cmk at 37  °  C for 45 min and precipitated with avidin beads. Western blots of the protein elute and the lysate input were 
probed with anti  –  caspase-1 or anti  –  caspase-11 antibodies. F, FliIshR1; P, pSRP. Error bars represent SD of duplicates; *, P   <   0.05; **, P   <   0.01.     329 FLIGHTLESS-1 REGULATES CASPASES   •   LI ET AL.
endogenous caspase-1  –  like proteolytic activity against the 
colorimetric peptide substrate Ac-YVAD-pNA in Flightless-I 
stable knockdown cells and control cells (Fig. S4 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200711082/DC1). 
Under unstimulated conditions, we detected higher spontaneous 
caspase-1 – like  protease activity in Flightless-I stable knockdown 
cells than in the control cells. However, after 12 h of LPS stimu-
lation, caspase-1  –  like protease activity was enhanced in both 
Flightless-I stable knockdown cells and control cells to a simi-
lar level (Fig. S4 A). 
 To  specifi  cally determine the effect of Flightless-I knock-
down on caspase-1 activation, because YVAD-pNA is not an ab-
solutely specifi  c substrate for caspase-1, we labeled the active 
caspase-1  –  like proteases in the total cell lysate from unstimu-
lated or LPS-treated cells with biotinylated YVAD-cmk. The la-
beled proteins were precipitated with avidin beads and the protein 
elute was analyzed by Western blotting with anti  –  caspase-1 and 
anti  –  caspase-11 antibodies (  Fig. 5 H  ). LPS stimulation alone did 
not induce the cleavage of either caspase-11 or caspase-1. LPS 
treatment enhanced the labeling of both full-length active cas-
pase-1 and caspase-11 by biotinylated YVAD-cmk. Interestingly, 
LPS treatment induced a higher level of active caspase-1 labeled 
by biotinylated YVAD peptide in Flightless-I stable knockdown 
cells than in the control cells. In contrast, the level of active cas-
pase-11 was not altered by the changes in the level of Flightless-I 
expression (  Fig. 5 H  ). Thus, endogenous Flightless-I specifi  cally 
regulates the activation of caspase-1 but not caspase-11, which is 
consistent with the in vitro data that recombinant Flightless-I 
inhibits caspase-1 but not caspase-11 activity (  Fig. 4, B and C  ). 
After LPS plus ATP stimulation, we did not observe the cleav-
ages of either caspsae-1 or pro-IL-1     in the cell lysate (Fig. S3, 
C and D), however, there was increased cleavage of both cas-
pase-1 and pro-IL-1     in the culture media of Flightless-I knock-
down cells compared with control cells (Fig. S3, E and F), which 
is consistent with the ELISA assay result in   Fig. 5 G  . 
  Flightless-I inhibits caspase-1 
as a pseudosubstrate 
  Because overexpression of Flightless-I could increase the distri-
bution of caspase-11 into the Triton X-100  –  insoluble LSP fraction 
(  Fig. 2 D  ), we examined whether overexpression of Flightless-I 
had the same effect on caspase-1. Caspase-1 was present pre-
dominantly in the Triton X-100  –  soluble HSS fraction (  Fig. 6 A  ). 
Expression of full-length Flightless-I, the LRR domain, or the 
GLD domain increased the distribution of caspase-1 into the 
Triton X-100  –  insoluble LSP fraction. Coexpression of Flightless-I 
with caspase-1 in COS cells also enriched the localization of cas-
pase-1 at the cell leading edge (Fig. S4 B). When the full-length 
caspase-11 or the p30 domain of caspase-11 was overexpressed, 
we observed a C-terminal cleavage fragment of the C-terminal 
HA-tagged Flightless-I around 100 kD in the LSP fraction, rec-
ognized by an anti-HA antibody (  Fig. 2 B  , arrowhead). In the 
LSP fraction from the cells transfected with caspase-1 expression 
vector (  Fig. 6 B  ), two additional Flightless-I C-terminal frag-
ments were observed, one around 90 kD (  Fig. 6 B  , single aster-
isk) and the other around 60 kD (double asterisks), as well as the 
100-kD fragment (arrowhead). 
  To determine whether caspase-1 could cleave Flightless-I 
directly in vitro, we used in vitro translated [ 
35 S]Met-labeled 
Flightless-I as a substrate and examined the cleavage by auto-
radiograph. There were four prominent in vitro cleavage products 
of Flightless-I generated in the presence of caspase-1 (  Fig. 6 C  , 
lines). The cleavage of Flightless-I was inhibited in the presence 
of caspase-1 inhibitor YVAD-cmk (Fig. S4 C). The cleavage of 
Flightless-I by caspase-1, however, is less effi  cient than that of 
pro-IL-1     ( Fig.  6  C ). 
  We searched for potential canonical caspase cleavage 
sites on Flightless-I using the ExPASy Proteomics Server 
(http://ca.expasy.org/) and found only one potential cleavage 
site (Asp526) for caspase-1 and no site for any other caspases. 
This potential caspase-1 recognition site ( 
523 YEADC 
527  ) is lo-
calized at the GLD domain of Flightless-I and evolutionarily 
conserved in the Flightless orthologues of   D. melanogaster , 
human, mouse, and rat (  Fig. 6 D  ). Interestingly, the sequence, 
YEADC (P4-P1    ), is highly reminiscent of the pseudosubstrate 
recognition site (LVADC) of CrmA, a potent caspase-1 inhibi-
tor identifi  ed from the cowpox virus (  Ray et al., 1992  ). CrmA 
forms an inhibitory complex with caspase-1 in its intact form 
(  Komiyama et al., 1994  ). To determine whether caspase-1 
cleaves after Asp526 of Flightless-I, we mutated Asp526 to 
Glu526 and cotransfected expression constructs of C-terminal 
HA-tagged Flightless-I (wild type [wt]) or Flightless-I (D526E) 
together with caspase-1 into 293T cells. The cleavage of Flight-
less-I was detected with an anti-HA antibody. The cleavage at 
Asp526 is expected to generate a C-terminal fragment of Flight-
less-I around 90 kD. Surprisingly, D526E mutation of Flight-
less-I appeared to have enhanced the caspase-1  –  dependent 
cleavage at the predicted Asp526 site as the level of the 90-kD 
fragment was increased (  Fig. 6 E  , single asterisk) without af-
fecting the production of the 100-kD fragment (  Fig. 6 E  , arrow-
head) or the 60-kD fragment (  Fig. 6 E  , double asterisk) in 293T 
cells. Because the requirement of an Asp at the P1 position is 
recognized as a key factor for caspase cleavage (  Thornberry 
et al., 1997  ), this result suggests that Flightless-I is an unusual 
substrate for caspase-1. 
  To further characterize the requirement of Asp526 for 
caspase-1  –  dependent cleavage, we generated a D526A Flight-
less-I mutant. Interestingly, in the in vitro cleavage assay, the 
Flightless-I (D526A) mutant had a signifi  cantly reduced level 
of the 90-kD cleavage band (  Fig. 6 F  , single asterisk) but an en-
hanced level of 100-kD cleavage band ( Fig. 6 F , arrowhead). Con-
sistent with the in vitro result, the expression of D526A Flightless-I 
mutant with caspase-1 in 293T cells completely abolished the 
appearance of the 90-kD fragment, whereas that of the D526E 
Flightless-I mutant led to an increased level of the 90-kD frag-
ment compared with that of the wt (  Fig. 6 G  , single asterisk). 
  To determine the requirement of Asp526 for Flightless-I 
to inhibit caspase-1 activation, we coexpressed wt, D526A, and 
D526E Flightless-I with caspase-1 in 293T cells. Both Flightless-I 
D526A and D526E mutants were less effi  cient in inhibiting cas-
pase-1 activation than wt Flightless-I (  Fig. 6 H  ). The Flightless-I 
D779E mutant, which did not affect caspase-1  –  dependent Flight-
less-I cleavage (  Fig. 6, F and G  ), had a similar inhibitory effect on 
caspase-1 activation as wt Flightless-I (  Fig. 6 H  ). These results JCB • VOLUME 181 • NUMBER 2 • 2008  330 
  Figure 6.       Flightless-I inhibits caspase-1 as a pseudosubstrate.   (A) Overexpression of full-length Flightless-I or the LRR domain and the GLD domain of Flight-
less-I increased the distribution of caspase-1 in the Triton X-100  –  insoluble LSP fraction. The experimental procedure was the same as in   Fig. 2 D  . A Western 
blot of the proteins in each fraction was probed with anti  –  caspase-1 antibody. (B) Overexpression of caspase-1  –  induced Flightless-I cleavage in the Triton 
X-100  –  insoluble LSP fraction. The cell lysates of 293T cells expressing C-terminal HA-tagged Flightless-I were fractionated as in   Fig. 2 B  . A Western blot of 
the proteins in each fraction was probed with an anti-HA antibody. (C) Caspase-1 cleaves Flightless-I in vitro. Recombinant caspase-1 was incubated with 
[ 
35  S]Met labeled in vitro translated pro-IL-1     or Flightless-I at 30  °  C for 1.5 h in 20-  μ  l volume. Cleavage of pro-IL-1     or Flightless-I was visualized by auto-
radiography. The cleavage products of Flightless-I are indicated with solid lines. (D) Sequence alignment of Flightless-I and CrmA at caspase-1 recognition 
sites. Potential cleavage is between the P1 and P1     positions. (E) Mutation of Asp526 to Glu526 on Flightless-I  –  enhanced caspase-1  –  dependent cleavage. 
Expression vectors of C-terminal HA-tagged Flightless-I (wt) and Flightless-I (D526E) mutant at 1   μ  g were cotransfected with the indicated amount of cas-
pase-1 plasmid into 293T cells. Western blots of the proteins in the Triton X-!00  –  insoluble LSP fraction were probed with an anti-HA antibody. (F) Asp526 
on Flightless-I is a caspase-1 cleavage site in vitro. Recombinant caspase-1 (0.5 U) was incubated with [ 
35  S]Met labeled in vitro translated wt or indicated 
point mutants of Flightless-I at 30  °  C for 1.5 h in 20-  μ  l volume. The cleavage of Flightless-I was visualized by autoradiography. The black line indicates that 
intervening lanes have been spliced out. (G) Asp526 on Flightless-I is a caspase-1  –  dependent cleavage site in vivo. C-terminal HA-tagged wt and indicated 
point mutant of Flightless-I (1   μ  g cDNA plasmid) was coexpressed in 293T cells with caspase-1 (0.5   μ  g). 24 h after transfection, cells were directly lysed in 331 FLIGHTLESS-1 REGULATES CASPASES   •   LI ET AL.
and caspase-11 may be activated without cleavage and cell 
death, whereas caspase-1 cleavage and secretion of mature 
IL-1     follow cell death. This is consistent with the activation 
of other caspases with long prodomains such as caspase-2, -8, -9, 
and -10, which can be achieved by dimerization and oligo-
merization, and the cleavage of initiator caspases stabilizes 
the active enzymes (  Acehan et al., 2002  ; for review see 
  Boatright and Salvesen, 2003  ;   Chang et al., 2003  ;   Huang 
et al., 2007  ). 
  The protein inhibitors of caspase-1 so far are divided into 
two categories. The fi  rst category binds to the CARD domain of 
the caspase-1 and interferes with caspase-1 oligomerization, 
such as Iceberg and COP, which are nonviral but induced by in-
fl  ammatory stimuli and thus regulated in a signal-dependent 
fashion (  Humke et al., 2000  ;   Druilhe et al., 2001  ;   Lee et al., 
2001  ). The second category contains a caspase-1 substrate rec-
ognition sequence and functions as an inhibitory substrate, 
such as CrmA and p35, which are both virally derived. CrmA 
(a cowpox virus product) was the fi  rst caspase-1 inhibitor iden-
tifi  ed (  Ray et al., 1992  ). Cowpox viruses use CrmA to bind ac-
tive caspase-1 to reduce the defensive infl  ammatory response 
trigged by IL-1    . The pseudosubstrate recognition region of 
CrmA has the residues LVADC (P4-P1-P1    ). CrmA remains 
intact after binding to caspase-1 to form an inhibitory complex 
( Komiyama et al., 1994 ). PI-9 is a close mammalian homologue 
of CrmA based on the sequence. The pseudosubstrate region 
has residues VVAEC (P4-P1-P1    ), and the acidic residue (P1) 
in its pseudosubstrate region is a glutamate residue rather than 
the aspartate found in CrmA (  Annand et al., 1999  ). p35 is a 
baculoviral protein that can block the defensive apoptotic re-
sponse of insect cells to viral infection (  Clem et al., 1991  ). 
The pseudosubstrate region of p35 has the residues DQMDG 
(P4-P1-P1    ). After it is cleaved after its P1 residue by cas-
pases, the cleaved subunits of p35 remain in an inhibitory 
complex with the caspases (  Zhou et al., 1998  ). Flightless-I 
inhibits caspase-1 in a very similar way to CrmA. The pseudo-
substrate region has the residue YEADC (P4-P1-P1   ).  Both 
converting it to a poorer or better substrate of caspase-1 
reduced the ability of Flightless-I to inhibit caspase-1 (  Fig. 6  ). 
Flightless-I could inhibit caspase-1 activation at the dose when 
Flightless-I was not cleaved by caspase-1 (  Figs. 3 C and 6 E  ), 
which suggests that the cleavage of Flightless-I is not required 
for its inhibitory activity. The residues  
523 YEADC 
527   lie in the 
GLD domain of Flightless-I. The LRR domain of Flightless-I 
alone (aa 1  –  400) also contains the inhibitory activity (  Fig. 3 C  ), 
although it is weaker than the GLD domain alone (aa 401  –
  1,272). How the LRR domain inhibits caspase-1 activation re-
mains to be clarifi  ed. Overall, the interaction between Flightless-I 
and proinfl  ammatory caspases identifi  ed in this study demon-
strates a novel mechanism by which caspases are regulated in 
living cells. 
suggest that the caspase-1 recognition site ( 
523 YEADC 
527 )  on 
Flightless-I, but not the cleavage per se, is a critical factor in de-
termining the ability of Flightless-I to inhibit caspase-1 because 
converting it to noncleavable site (D526A) reduced its inhibitory 
effect. However, converting it to a better substrate (D526E) also 
reduced the inhibitory effect of Flightless-I on caspase-1. These 
unusual properties of Flightless-I as a substrate and inhibitor of 
caspase-1 are reminiscent of what has been described for CrmA 
(  Komiyama et al., 1994  ), which suggests that Flightless-I might 
function as an inhibitor of caspase-1 in living cells through a 
mechanism similar to that of CrmA. 
  Discussion 
  We described here the interaction of a gelsolin family actin-
remodeling protein, Flightless-I, with proinfl  ammatory caspases 
caspase-11 and caspase-1. A connection between caspase-11 
and actin cytoskeleton remodeling has been demonstrated be-
fore in our previous study about caspase-11 in promoting Aip1-
dependent actin depolymerization and cell migration (  Li et al., 
2007  ). Our study predicted that by interacting with the cytoskel-
etal network in the lamellopodia, caspase-11 might be present 
at the leading edge to regulate cell migration. In this study, 
we show that Flightless-I interacts with the catalytic domain 
(p30 domain) of caspase-11. The interaction of caspase-11 with 
Flightless-I increases the partition of caspase-11 into the Triton 
X-100  –  insoluble actin bundle fraction, where Flightless-I pref-
erentially exists, and also increases the distribution of caspase-11 
at the F-actin  –  rich region of the cell leading edge (  Fig. 2  ). 
Therefore, the interaction of caspase-11 and Flightless-I pro-
vides a potential mechanism for targeting caspase-11 to the ac-
tin network at the cell front to regulate cell movement. 
  We show that Flightless-I also interacts with caspase-1. 
Flightless-I inhibits caspase-1 activation and IL-1     maturation, 
whereas its interaction with caspase-11 has no effect on cas-
pase-11 activity (  Figs. 4   and   5  ). Both the LRR domain and the 
GLD domain of Flightless-I could interact and inhibit caspase-1 
activation (  Fig. 3  ), which suggests that Flightless-I might act as 
an inhibitory  “ clamp ”  on caspase-1. The GLD domain of Flight-
less-I has also been shown to be able to bind the toll  –  interleukin 1 
receptor domains of MyD88 and TLR4, thereby disrupting the 
MyD88  –  TLR4 complex formation (  Wang et al., 2006  ). There-
fore, the functions of the GLD domain of Flightless-I might 
have been expanded signifi  cantly beyond the   “  gelsolin-like  ”   
actin remodeling. 
  In response to LPS simulation, we observed full-length 
active caspase-1 and caspase-11 as indicated by the labeling 
of biotinylated caspase substrate (  Fig. 5 H  ) associated with 
in effi  cient IL-1     secretion (  Fig. 5 G  ). After LPS plus ATP 
treatment, caspase-1 is cleaved and IL-1     secretion is dramat-
ically increased (  Figs. 5 G   and S3). We propose that caspase-1 
2  ×   SDS loading buffer. A Western blot of the total cell lysate was probed with anti-HA antibody. (H) Asp526 on Flightless-I is critical for the inhibitory effect 
of Flightless-I on caspase-1 activation. 293T cells were transfected and lysed as in G. Western blot of the total cell lysate was probed with an anti  –  caspase-1 
antibody. IL-1     secretion was measured as in   Fig. 3 D   except that 0.05   μ  g of pro-IL-1     plasmid and 0.5   μ  g of caspase-1 plasmid were used for transfection. 
Error bars represent SD of duplicates; *, 90-kD Flightless-I fragment; **, 60-kD Flightless-I fragment; arrowhead, 100-kD Flightless-I fragment.     
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An in vitro cleavage reaction was performed in the buffer containing 
20 mM Tris-HCl, pH7.5, 0.1 mM EDTA, and 10 mM DTT at 30  °  C for 1.5 h. 
The cleavage was visualized by autoradiography. 
  Cleavage of 200   μ  M of colorimetric substrate Ac-YVAD-pNA 
(for caspase-1) and Ac-LEHD-pNA (for caspase-11) were performed in a 
buffer containing 25 mM Hepes, pH 7.4, 0.1% CHAPS, 10% glycerol, 1 mM 
EDTA, and 10 mM DTT at 37  °  C and measured at an OD of 405 nm on a 
Victor plate reader (PerkinElmer). 
  Biotinylated substrate labeling of active caspases 
  The experimental methods were performed according to Marsden et al. 
(  2002  ) with minor modiﬁ  cations. J774 cells were treated with 1   μ  g/ml LPS 
for 12 h. Lysates were made in 10 mM Hepes-KOH, pH 7.4/2 mM 
EDTA/0.1% CHAPS/5mM DTT/1mM PMSF. To label active caspases, 20   μ  M 
biotin-YVAD-cmk (EMD) was added to lysates, which were incubated for 
45 min at 37  °  C. Lysates were then incubated with Neutravidin beads 
(Thermo Fisher Scientiﬁ  c) for 2 h at 4  °  C. After extensive washing, biotinyl-
ated polypeptides were eluted by directly boiling the beads in 2  ×   SDS 
sample buffer. 
  Protein puriﬁ  cation 
  The Flightless-I open reading frame was PCR ampliﬁ  ed and subcloned into 
a pGEX-6P-1 vector at BamHI  –  XhoI sites. Recombinant GST  –  Flightless-I was 
puriﬁ  ed as described previously (  Frangioni and Neel, 1993  ). His-tagged 
caspase-11 was puriﬁ  ed as described previously (  Kang et al., 2000  ). 
  Flightless-I RNAi in J774 cells 
  Synthesized siRNA oligos targeting Flightless-I (siGENOME set of four 
duplexes) and nontargeting control oligos were obtained from Thermo 
Fisher Scientiﬁ  c. siRNA oligos were electroporated into J774 cells using 
a nucleofector machine (Amaxa) according to the manufacturer  ’  s instruc-
tions. The Flightless-I level was measured by Western blotting 48 h after 
transfection. The sequences were: siRNA No. 1, 5    -GAAGAUACACA-
CUAUGUUAUU-3     (sense) and 5    -PUAACAUAGUGUGUAUCUUCUU-3     
(antisense); siRNA No. 3, 5    -CAACAUUGACUUCUCGCUAUU-3     (sense) 
and 5    -PUAGCGAGAAGUCAAUGUUGUU-3     (antisense); siRNA No. 4, 
5    -AAACAAGAAUGAGCGGAAAUU-3     (sense) and 5    -PUUUCCGCU-
CAUUCUUGUUUUU-3     (antisense); and nontargeting control siRNA, 
5    -UAGCGACUAAACACAUCAA-3     (sense). 
  Oligonucleotides corresponding to the sense 5    -GAAGATACACACTAT-
GTTA-3     and antisense 5    -TAACATAGTGTGTATCTTC-3     (FliIshR1) for mouse 
Flightless-I were annealed and inserted into an pSRP-puro vector at BglII  –  XhoI 
sites. pSRP-FliIshR1 or pSRP vector plasmids were transfected into 293T cells for 
retrovirus production. J774 cells were infected with the virus and selected with 
2   μ  g/ml puromycin for 1 wk to generate stable knockdown cells. 
  Online supplemental material 
  Fig. S1 shows the interaction between endogenous caspase-1 and Flightless-I 
and the binding speciﬁ  city of Flightless-I with caspase-1/caspase-11. Fig. S2 
shows the inhibitory activity of CrmA on caspase-1. Fig. S3 shows the full 
gel scans of caspase-1 and pro-IL-1     expression and cleavage patterns in 
cell lysates and culture media of Flightless-I knockdown cells. Fig. S4 shows 
caspase-1  –  like protease activity in Flightless-I knockdown cells, caspase-1 
localization in COS cells, and the in vitro cleavage of Flightless-I (wt) and Flight-
less-I (D526E) mutant. Table S1 shows caspase-11 –  induced cell death in HeLa 
cells with or without Flightless-I coexpression. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200711082/DC1. 
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  Materials and methods 
  Reagents 
  Antibodies used were anti  –  Flightless-I (Santa Cruz Biotechnology, Inc.), 
anti-HA (Covance), anti  –  pro-IL-1     (R  &  D Systems), and anti  –  caspase-1 and 
anti  –  caspase-11 (  Wang et al., 1998  ). Anti-Flag M2 agarose beads were 
obtained from Sigma-Aldrich. LPS was obtained from Sigma-Aldrich. 
Ac-YVAD-pNA and Ac-LEHD-pNA were obtained from Axxora, LLC. Recom-
binant caspase-1 was obtained from Millipore. 
  Flag-tagged afﬁ  nity puriﬁ  cation and mass spectrometry analysis 
  Experiment details have been described previously (  Li et al., 2007  ). Pep-
tide sequences identiﬁ  ed from the 50-kD band in the J774-C11-C254G 
lane (  Fig. 1 A  ) corresponding to mouse LRRFIP2 were KLAGEKDELLSQIRK, 
NDGMSGDLAGLQNGSDLQFIEMQR, AEQDIATLEQSISR, TAAENAEKIE-
DELKAER, TAQDKIEEMEMTNSHLAK, DIYDLKDQIHDVEGR, ESLSEVEEK, 
AMVSNAQLDNEKNNLIYQVDTLK, and DVIEEQEEQMAEFYRENEEK. 
  Construction of mouse Flightless-I, LRRFIP2, and caspase-11 
expression plasmids 
  Plasmid containing cDNA encoding full-length mouse Flightless-I was ob-
tained from the American Type Culture Collection (IMAGE clone ID, 
5040746). The cDNA fragments encoding the full-length, LRR (aa 1  –  400), 
and GLD (aa 398  –  1,272) of Flightless-I were PCR ampliﬁ  ed from the IMAGE 
clone and inserted into a pCDNA3-HA vector at HindIII  –  XhoI sites. Flightless-I 
D526A, D526E, and D779E mutant constructs were generated from an HA-
tagged wt Flightless-I plasmid using the site-directed mutagenesis kit (Strata-
gene). A plasmid containing full-length mouse LRRFIP2 cDNA was obtained 
from the American Type Culture Collection (IMAGE clone ID, 4217995). 
The open reading of full-length LRRFIP2 cDNA was PCR ampliﬁ  ed from the 
IMAGE clone and inserted into a pCDNA3-HA vector at EcoRI  –  NotI sites. 
Generation of the full-length and truncated mutant constructs of caspase-11 has 
been described previously (  Li et al., 2007  ). The EGFP-tagged caspase-11 
construct was generated in EGFP-N2 vector with the full-length caspase-11 
open reading frame inserted at EcoRI  –  BamHI sites. 
  Fractionation of actin pools 
  Actin pools were assayed by differential centrifugation of Triton X-100 cell ex-
tracts (  Yamamoto et al., 2001  ). Cells were lysed in Triton buffer (150 mM NaCl, 
50 mM Tris-HCl, pH7.5, 1 mM EDTA, and 1% Triton X-100) with protease in-
hibitor (Roche). Lysates were centrifuged sequentially at 15,900   g   for 2 min and 
then at 366,000   g   for 20 min. The pellets from each centrifugation step were 
resuspended into the original lysate volume. Samples were boiled in SDS gel 
sample buffer and equal fractions of each pool were analyzed by SDS-PAGE. 
  Immunostaining 
      2.5   ×   10 
4   HeLa or COS cells were seeded on 18-mm-diameter coverslips in 
a 12-well plate overnight. 1   μ  g of total DNA was transfected using TransitLT1 
reagent (Mirus). Cells were ﬁ  xed 24 h after transfection with 4% paraformal-
dehyde for 20 min. After permeabilization and blocking with 10% FBS/0.1% 
Triton X-100/PBS for 30 min, cells on coverslips were incubated with anti-HA 
mouse or rat monoclonal antibody (1:500 dilution) in 1% FBS/0.1% Triton 
X-100/PBS at 4  °  C overnight. Cells were incubated with goat anti  –  mouse-IgG  –
  Alexa 594, goat anti  –  mouse-IgG  –  Aexa 647, or goat anti  –  rat-IgG  –  Alexa 488 
(Invitrogen;     1:250  –  1:500 dilution) with or without rhodamine-phalloidin (In-
vitrogen; 1:200 dilution) for 45 min. After cell nuclei were stained with Hoechst 
33334 for 10 min, coverslips were mounted onto glass slides with 1 mg/ml 
p-phenylalanine diamine/90% glycerol/PBS. Images were taken using a ﬂ  uo-
rescence microscope (E800; Nikon) with a 40  ×   NA 0.75 objective (Nikon) 
and Spot Advanced software (Diagnostic Instruments, Inc.;   Fig. 3 E  ) or a micro-
scope (TE2000; Nikon) with a C1 confocal laser scanning head with a 
60x NA 1.4 oil objective and EZ-C1 3.50 software (Nikon;   Fig. 2, E  –  G  ). 
  Assay for IL-1     secretion 
      3.5   ×   10 
5   per well 293T cells were seeded in 6-well plates overnight. 
cDNA constructs of pro-IL-1    , caspase-1, caspase-11, and Flightless-I were 
transfected using the calcium phosphate precipitation method (  Wang et al., 
1996  ). In some cases, 100   μ  M zVAD-fmk was added to the culture media af-
ter the addition of transfection mixture. 24 h after transfection, the cell lysate 
was collected for Western blotting. IL-1     in the culture media was measured 
by an ELISA kit (R  &  D Systems). 
  In vitro caspase-1 cleavage assay 
  Pro-IL-1     and Flightless-I were in vitro synthesized using TNT Quick coupled 
transcription/translation systems (Promega) with [ 
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